https://www.avient.com/products/long-fiber-technology
Complēt™ PKE Formulations
Complēt™ REC Formulations
Surround™ EMI/RFI Shielding Formulations
https://www.avient.com/news/avient-launches-nymax-bio-low-water-absorption-and-bio-based-polyamides
SHANGHAI – March 16, 2022 – Avient today launched Nymax™ BIO Formulations, a line of bio-based polyamide materials that help customers reach their sustainability goals.
Nymax BIO formulations are currently manufactured in Asia and are available globally.
About Avient
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=43
Avient Resources
Avient Resources
Electrical Junction Boxes
https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/oncolor-naturals-colorants
In addition, they can be formulated with ingredients such as almond shells, natural fibers, and wood particles to deliver natural aesthetics.
Browse and download our literature to learn more about Avient solutions and services.
See how our specially formulated colorants can help differentiate your brand
https://www.avient.com/products/polymer-colorants/fluoropolymer-color-concentrates/colorant-chromatics-dispersed-pigments-ptfe
Pigment formulations can be tailored for specific applications
Browse and download our literature to learn more about Avient solutions and services.
Explore Colorant Chromatics's broad portfolio, markets and applications, and how Avient can provide the highest levels of service (English language version).
https://www.avient.com/products/polymer-colorants/liquid-color-concentrates/mesa-liquid-colorants
Broad range of additive packages that can combine in one formulation
Browse and download our literature to learn more about Avient solutions and services.
Video: Avient Innovation Centers
https://www.avient.com/news/specialty-polymer-solutions-avient-improved-durability-and-sustainability-healthcare-products-pharmapack-2023
Caption: Avient highlights polymer formulations that increase the durability of healthcare products and bio-based polymer solutions that improve the sustainability of medical devices and pharmaceutical packaging.
About Avient
Avient Announces Quarterly Dividend...
https://www.avient.com/knowledge-base/article/medical-stoppers-improved
Versaflex™ HC TPE is formulated to produce low coring levels in resealing applications.
This formulation meets the requirements of the ISO 15759 standard for medical infusion equipment, and can be steam autoclaved using temperatures up to 121°C.
Purity and cleanliness are crucial for polymers used in healthcare applications, and this formulation enhances purity not only because it offers low coring levels, but because it is made without cross-linking agents that can potentially leach into the container and interact with the sensitive pharmaceutical product.
https://www.avient.com/sites/default/files/2021-11/artisan-ar7300-pre-colored-formulation-processing-guide.pdf
Artisan™ AR7300
PRE-COLORED FORMULATIONS
PROCESSING GUIDE
Artisan™ Pre-Colored Thermoplastics
Artisan™ AR7300 pre-colored thermoplastics are customized ABS formulations to help manufacturers achieve
brilliant and high-gloss metallic effect, excellent chemical resistance, and scratch resistance.
Avient makes no warranties or
guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
You have the responsibility to conduct full-scale end-product performance testing
to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/investor-center/news/polyone-host-investor-conference-call
The company adds value to global customers and improves sustainability through formulating materials, such as:
the time required to consummate the acquisition of Clariant's color and additive masterbatch business; the satisfaction or waiver of conditions in the purchase agreements; any material adverse changes in Clariant's color and additive masterbatch business; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed acquisition of Clariant's color and additive masterbatch business; our ability to achieve the strategic and other objectives relating to the proposed acquisition of Clariant's color and additive masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's color and additive masterbatch business and achieve the expected results of the acquisition of Clariant's color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.